ENTITY
Shanghai Haohai Biological Technology

Shanghai Haohai Biological Technology (6826 HK)

136
Analysis
Health Care β€’ China
Shanghai Haohai Biological Technology engages in the research, development, manufacture, and sale of biomedical materials and pharmaceutical products. The company focuses on therapeutic areas including ophthalmology, medical aesthetics and wound care, orthopedics, and anti-adhesion and hemostasis, with key products such as intraocular lenses, hyaluronic acid dermal fillers, and sodium hyaluronate injections. It is headquartered in Shanghai, China, and was founded in 2007.
more
bullishβ€’Tencent
β€’30 Sep 2022 09:50

Shanghai/​​​​​​​​​​​​​​Shenzhen Southbound Connect: Weekly Moves (30 September 2022)

Inside is a recap of movements in the Shanghai/Shenzhen-HK Connect. Overall, the net inflow over the past week was ~US$1.3bn, split (-US$0.75bn)...

Logo
513 Views
Share
bullishβ€’Quantitative Analysis
β€’25 Sep 2022 10:20

Hong Kong Connect Flows (Sep 23rd): Tencent, CNOOC

We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Tencent Holding (700 HK) and CNOOC (883 HK).

Logo
554 Views
Share
bullishβ€’Quantitative Analysis
β€’25 Sep 2022 10:20

A-H Premium Weekly (Sep 23rd): China Tourism A-H at All Time Low

We analyzed A-H premium changes in the past week and highlight weekly changes in A-H premium for Angang, Flat Glass, Zoomlion, China Tourism, China...

Logo
436 Views
Share
bearishβ€’Quantitative Analysis
β€’26 Jun 2022 11:20

A-H Premium Weekly: Zhejiang Shibao, PICC, CRRC

We highlight week-on-week A-H premium changes in stocks including Zhejiang Shibao, PICC, CRRC, Shandong Xinhua, and Shenwan Hongyuan.

Logo
412 Views
Share
bullishβ€’Quantitative Analysis
β€’05 Jun 2022 11:53

A-H Premium Weekly: Remegen, CNOOC, COSCO Shipping

We highlight A-H premium changes for stocks including Remegen, CNOOC, COSCO Shipping, Cansino, Nanjing Panda, Shenzhen Hepalink, SH Fudan, SH...

Logo
502 Views
Share
x